+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol



Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol



European Neuropsychopharmacology 4(2): 119-126



Plasma haloperidol (HL) and reduced haloperidol (RH) levels were measured in 60 schizophrenic patients treated with high to very high HL doses of 40-200 mg/day. Plasma samples were obtained at steady-state conditions and 10-12 h after the evening dose and prior to the morning dose. RH/HL ratios were shown to be dose-dependent. In the lowest dose group of 40-45 mg/day, 77% of the patients had RH/HL ratios < 1.0. At the higher dose of 60-80 mg/day, these results were reversed as 79% of the patients had RH/HL ratios > 1.0. All patients with HL doses greater than 100 mg/day had RH/HL ratios > 1.0. All patients safely tolerated the high haloperidol dosages and only five patients had extrapyramidal side effects that were unresponsive to trihexyphenidyl. Therapeutic improvement was not observed in each patient. Based upon the dose-dependent increase in the RH/HL ratios in schizophrenic patients, the possible mechanism of a 'therapeutic' window for HL is discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046998808

Download citation: RISBibTeXText

PMID: 7919941

DOI: 10.1016/0924-977x(94)90005-1


Related references

The plasma haloperidol and reduced haloperidol concentrations in chinese schizophrenic patients relationship between reduced haloperidol haloperidol ratio and red blood cell haloperidol reductase activity. Human Psychopharmacology 7(2): 123-128, 1992

The plasma haloperidol and reduced haloperidol concentrations in chinese schizophrenic patients: Relationship between reduced haloperidol/haloperidol ratio and red blood cell haloperidol reductase activity. Human Psychopharmacology: Clinical and Experimental 7(2): 123-128, 1992

Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients. Psychiatry Research. 57(2): 101-108, 1995

Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection: Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol. Journal of Chromatography B Biomedical Applications 656(2): 373-381, 1994

Measurement of haloperidol reductase activity in red blood cells and reduced haloperidol to haloperidol ratios in plasma in oriental psychiatric patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 14(6): 941-948, 1990

Schizophrenic patients treated with haloperidol decanoate Clinical evaluations Plasma and red blood cell concentrations of haloperidol and its reduced metabolite. Therapie (Paris) 0(Suppl. ): 241, 1995

Steady state plasma concentrations of haloperidol and reduced haloperidol after oral haloperidol in schizophrenic patients and analysis of factors determining their concentrations in hair. Japanese Journal of Pharmacology 55(Suppl. 1): 102P, 1991

Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: Clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid. Progress in Neuro Psychopharmacology and Biological Psychiatry 19(7): 1119-1135, 1995

Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol. Psychopharmacology 106(4): 517-522, 1992

Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients. Psychiatry Research 38(3): 215-225, 1991

Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid. Journal of Clinical Psychopharmacology 9(2): 130-132, 1989

Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. Journal of Clinical Psychopharmacology 4(3): 138-142, 1984

Haloperidol and reduced haloperidol concentrations in plasma from chronic schizophrenic patients. European Journal of Pharmacology 183(6): 2301-2302, 1990

Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients. Journal of Clinical Psychopharmacology 9(3): 186-190, 1989

Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients. Psychiatry Research 31(2): 111-120, 1990